Kangstem Biotech Co. Ltd Working Capital to Net Assets Ratio
Kangstem Biotech Co. Ltd working capital to net assets ratio. Kangstem Biotech Co. Ltd (217730) has a Working Capital to Net Assets ratio of 41.5% as of June 2026. Working capital of ₩23.46 Billion (current assets of ₩31.38 Billion minus current liabilities of ₩7.93 Billion) is measured against net assets of ₩56.56 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Kangstem Biotech Co. Ltd's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Kangstem Biotech Co. Ltd (2015–2025)
Working capital to net assets ratio of Kangstem Biotech Co. Ltd from 2015 to 2025. This chart shows how Kangstem Biotech Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 41.5%, reflecting working capital of ₩23.46 Billion against net assets of ₩56.56 Billion KRW. See how many days can Kangstem Biotech Co. Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Kangstem Biotech Co. Ltd Working Capital to Net Assets Ratio by Year (2015–2025)
Kangstem Biotech Co. Ltd working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Kangstem Biotech Co. Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 217730 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.2% | ₩35.33 Billion | ₩69.06 Billion | ₩43.63 Billion | ₩8.30 Billion | ▲ +3.0 pp |
| 2024 | 48.2% | ₩20.80 Billion | ₩43.18 Billion | ₩28.53 Billion | ₩7.73 Billion | ▼ -3.9 pp |
| 2023 | 52.0% | ₩23.17 Billion | ₩44.52 Billion | ₩47.37 Billion | ₩24.20 Billion | ▼ -14.9 pp |
| 2022 | 66.9% | ₩31.64 Billion | ₩47.26 Billion | ₩45.91 Billion | ₩14.27 Billion | ▼ -3.8 pp |
| 2021 | 70.8% | ₩48.16 Billion | ₩68.07 Billion | ₩65.36 Billion | ₩17.19 Billion | ▲ +7.7 pp |
| 2020 | 63.0% | ₩32.54 Billion | ₩51.62 Billion | ₩44.75 Billion | ₩12.21 Billion | ▲ +13.8 pp |
| 2019 | 49.2% | ₩34.81 Billion | ₩70.72 Billion | ₩55.41 Billion | ₩20.60 Billion | ▼ -11.5 pp |
| 2018 | 60.7% | ₩28.94 Billion | ₩47.69 Billion | ₩48.99 Billion | ₩20.06 Billion | ▼ -19.7 pp |
| 2017 | 80.4% | ₩18.88 Billion | ₩23.47 Billion | ₩25.25 Billion | ₩6.37 Billion | ▼ -70.8 pp |
| 2016 | 151.2% | ₩34.74 Billion | ₩22.98 Billion | ₩37.97 Billion | ₩3.23 Billion | ▲ +76.2 pp |
| 2015 | 75.0% | ₩15.93 Billion | ₩21.24 Billion | ₩18.90 Billion | ₩2.97 Billion | — |